Puig to Fully Acquire Skincare Brand Isdin After Buying Remaining Stake from Esteve
Puig’s Growing Focus on Science-Led Skincare
Puig has agreed to acquire the remaining 50% stake in skincare brand Isdin from Corporación Químico-Farmacéutica Esteve, granting the Spanish beauty group full ownership of the dermocosmetics label. The deal strengthens Puig’s strategic push into dermatologist-recommended skincare, complementing its existing portfolio that includes luxury makeup brand Charlotte Tilbury. The acquisition follows years of joint ownership between Puig and Esteve, who co-founded Isdin in 1975. Financial terms of the transaction were not disclosed. The move comes as Puig seeks to expand its presence in high-growth dermocosmetics, a segment driven by increasing consumer demand for science-backed skincare solutions. Isdin, known for its photoprotection and anti-aging products, operates in over 50 countries and has a strong presence in European and Latin American markets.
Breaking News
Hollywood Elite Honor Carpenter, Theron, and Domingo at Academy Museum Gala
The Next Generation of Collagen: Small Peptides, Big Claims
The Impending Rise of Cobalt Blue in 2027 Fashion
The Secret to a Flawless Autumn Complexion is Sunscreen LayeringThe full acquisition of Isdin aligns with Puig’s broader strategy to deepen its expertise in dermocosmetics, a category that blends cosmetic appeal with clinical efficacy. Puig has increasingly invested in brands that emphasize dermatological validation, positioning itself to compete with established players like L’Oréal’s La Roche-Posay and Beiersdorf’s Eucerin. Isdin’s product lines, particularly its sunscreens and skin repair formulations, are frequently recommended by healthcare professionals, adding credibility to Puig’s beauty offerings. Industry analysts note that dermocosmetics are outpacing traditional cosmetics in growth, making Isdin a valuable asset for long-term portfolio resilience. Puig has not indicated plans to alter Isdin’s current management or distribution model post-acquisition.
How Will This Affect Isdin’s Market Position?
With full control, Puig can now integrate Isdin more closely into its global beauty operations, potentially accelerating innovation and expanding into new geographic regions. The company may leverage its marketing and retail expertise to boost Isdin’s visibility in premium channels, including dermatology clinics and high-end pharmacies. However, maintaining Isdin’s authentic, science-driven identity will be crucial to preserving trust among consumers and medical professionals. Esteve, which retains its own pharmaceutical and healthcare businesses, will continue to operate independently. The acquisition reflects Puig’s confidence in Isdin’s brand equity and its potential to contribute significantly to future revenue streams, particularly as skincare continues to outperform other beauty categories in key markets.
Why did Puig decide to buy the remaining stake in Isdin? Puig aims to strengthen its position in the fast-growing dermocosmetics sector by gaining full control of a brand with strong dermatologist backing and international reach.
Frequently Asked Questions
Will Isdin’s products or branding change after the acquisition? Puig has not announced any changes to Isdin’s formulations, branding, or operational independence, emphasizing continuity in its skincare approach.
What does this mean for Esteve’s involvement with Isdin? Esteve will no longer have ownership in Isdin but will continue to focus on its core pharmaceutical and healthcare activities separate from the beauty brand.